EUVIMEDEUVIMED entdecken
Crossref

Real‐world sequencing of second‐line systemic therapy and outcomes in metastatic pancreatic ductal adenocarcinoma: an analysis of the PURPLE registry

Asia-Pacific Journal of Clinical Oncology · 2026-11 · 22 (S6) · 28-28

DOI: 10.1111/ajco.70243 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Asia-Pacific Journal of Clinical Oncology, online erschienen am 19.11.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Real‐world sequencing of second‐line systemic therapy and outcomes in metastatic pancreatic ductal adenocarcinoma: an analysis of the PURPLE registry. Asia-Pacific Journal of Clinical Oncology, 22(S6), 28-28. https://doi.org/10.1111/ajco.70243

Vancouver

Real‐world sequencing of second‐line systemic therapy and outcomes in metastatic pancreatic ductal adenocarcinoma: an analysis of the PURPLE registry. Asia-Pacific Journal of Clinical Oncology. 2026;22(S6):28-28. doi:10.1111/ajco.70243

BibTeX
@article{euvimed2026,
  title = {Real‐world sequencing of second‐line systemic therapy and outcomes in metastatic pancreatic ductal adenocarcinoma: an analysis of the PURPLE registry},
  journal = {Asia-Pacific Journal of Clinical Oncology},
  year = {2026},
  volume = {22},
  number = {S6},
  pages = {28--28},
  doi = {10.1111/ajco.70243}
}
Kostenlos starten →